Paper36907112
The involvement of DDX3X in compression-induced nucleus pulposus pyroptosis.
Chi S and 7 others. Biochem Biophys Res Commun, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. The involvement of DDX3X in compression-induced nucleus pulposus pyroptosis. Papers, record 36907112. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36907112
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nucleus Pulposus | Major topic |
| Intervertebral Disc Degeneration | Major topic |
| Humans | |
| Rats | |
| Animals | |
| Interleukin-18 | |
| Pyroptosis | |
| NLR Family, Pyrin Domain-Containing 3 Protein | |
| Caspase 1 | |
| Inflammasomes | |
| DEAD-box RNA Helicases |
Source PubMed
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42889204 | Mechanistic study on components of Angelica Pubescens-Taxillus Chinensis in improving compression-induced intervertebral disc degeneration via piezo1/NF-κB signaling axis. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42889204 | PubMed |
| 42801360 | Rosiglitazone alleviates white matter injury by inhibiting NLRP3/capspase-1 mediated microglial pyroptosis via downregulating KLF4. | Exp Brain Res | 2026 | https://conductscience.org/library/papers/42801360 | PubMed |
| 41558602 | Decoding intervertebral disc degeneration pathomechanics: from mechanisms to therapeutic horizons. | J Adv Res | 2026 | https://conductscience.org/library/papers/41558602 | PubMed |
| 40688090 | Immune microenvironment in intervertebral disc degeneration: pathophysiology and therapeutic potential. | Front Immunol | 2025 | https://conductscience.org/library/papers/40688090 | PubMed |
| 38735906 | Silencing DDX3 Attenuates Interleukin-1β-Induced Intervertebral Disc Degeneration Through Inhibiting Pyroptosis. | Inflammation | 2025 | https://conductscience.org/library/papers/38735906 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP1 | 834 | PubTator's text mining | https://conductscience.org/library/genes/834 | NCBI Gene |
| DDX3X | 1654 | PubTator's text mining | https://conductscience.org/library/genes/1654 | NCBI Gene |
| IL18 | 3606 | PubTator's text mining | https://conductscience.org/library/genes/3606 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| NLRP3 | 114548 | PubTator's text mining | https://conductscience.org/library/genes/114548 | NCBI Gene |
| PYCARD | 29108 | PubTator's text mining | https://conductscience.org/library/genes/29108 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36907112
GET https://conductscience.org/api/papers/v1/36907112/authors